Pharmaceuticals, Biotechnology and Life Sciences
Patent has already been issued in other major markets including the U.S., EU, Japan and China PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite…
Third quarter reported net sales increased 1.0 percent year-over-year to $1.62 billion. Internal sales increased 0.3 percent year-over-year, driven by…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that management will host a conference…
The DEFINITIVE project (diagnostic HER2DX®-guided treatment for patients with early-stage HER2-positive breast cancer), led by FRCB-IDIBAPS, will be conducted across…
SARASOTA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a company focused on developing unique, intranasal nanoparticle pharmaceuticals…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–$VCYT—Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its Decipher Prostate Genomic…
WARREN, N.J.–(BUSINESS WIRE)–Tevogen Bio Holdings – Tevogen (Nasdaq: TVGN) Chief Information Officer and Head of company’s Artificial Intelligence Initiative, Tevogen.ai,…
SARASOTA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a company focused on developing unique, intranasal nanoparticle pharmaceuticals…
– Priority Review acceptance based on positive results of AGAVE-201 study WILMINGTON, Del.–(BUSINESS WIRE)–Incyte (Nasdaq:INCY) today announced that the U.S.…
– 2023 total net product sales of $726.4 million, reflecting 40% revenue growth. – Fourth quarter DAYBUE™ (trofinetide) net product…